Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AUC,”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02161770
What this trial is testing

Study to Assess the Blood Levels and Safety of AZD9291 in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment

Who this might be right for
Solid Tumours
AstraZeneca 30
Post-approval studies (Phase 4)Study completedNCT02047006
What this trial is testing

Dose-finding of Rivaroxaban in Hemodialysis

Who this might be right for
Chronic Renal Failure
AZ Sint-Jan AV 18
Large-scale testing (Phase 3)UnknownNCT06274294
What this trial is testing

Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous as Induction Therapy in Patients With Active CD or UC

Who this might be right for
Inflammatory Bowel Diseases
CMC Ambroise Paré 130
Not applicableEnded earlyNCT04244916
What this trial is testing

MPA AUC Monitoring in Patients Receiving MMF for Diffuse Cutaneous or Pulmonary Involvement in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Assistance Publique - Hôpitaux de Paris 2
Not applicableStudy completedNCT05689450
What this trial is testing

Probability of Optimal Target Attainment of Amikacin in Patients With Febrile Neutropenia During Treatment for a Hematological Disorder

Who this might be right for
Febrile Neutropenia (FN)
University Hospital, Basel, Switzerland 92
Testing effectiveness (Phase 2)Active Not RecruitingNCT06293365
What this trial is testing

Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease

Who this might be right for
Sjögrens DiseaseSystemic Lupus ErythematosusRheumatoid Arthritis
Novartis Pharmaceuticals 155
Early research (Phase 1)Study completedNCT01635023
What this trial is testing

A Randomized, Open Label Study to Compare the Current Phase II and Planned Phase III Capsule Formulation of AZD6244

Who this might be right for
Healthy Volunteers
AstraZeneca 27
Early research (Phase 1)Study completedNCT01392807
What this trial is testing

Open-label Study to Assess the Pharmacokinetics of NKTR-118 in Patients With Impaired Hepatic Function

Who this might be right for
Hepatic; Functional Disturbance
AstraZeneca 24
Early research (Phase 1)Study completedNCT04111614
What this trial is testing

Demonstrate the Equivalence of the Tofacitinib Oral Solution to the Tablet Formulation in Healthy Participants.

Who this might be right for
Healthy
Pfizer 12
Not applicableTemporarily pausedNCT01987687
What this trial is testing

Effect of Timing of a Post-exercise Oral Glucose Tolerance Test on Glycaemic Control.

Who this might be right for
Area Under Curve [N06.850.520.830.200]
Northumbria University 12
Early research (Phase 1)Study completedNCT01894256
What this trial is testing

Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal or Impaired Kidney Function

Who this might be right for
Solid Tumours
AstraZeneca 56
Early research (Phase 1)Study completedNCT01310322
What this trial is testing

A Study in Healthy Subjects and Mild Asthmatics to Investigate Pharmacokinetics of AZD5423 When Administered in Different Ways

Who this might be right for
HealthyAsthma
AstraZeneca 12
Early research (Phase 1)Study completedNCT02359045
What this trial is testing

Study in Healthy Subjects to Compare the Concentrations of the Omega-3 Fatty Acids EPA and DHA in Blood When Delivered as Three New Capsules in Relation to the Epanova® Capsule Under Fasting and Fed Conditions

Who this might be right for
Relative BioavailabilityAUCCmax+1 more
AstraZeneca 137
Early research (Phase 1)Study completedNCT01851265
What this trial is testing

D081AC00001 Food Interaction With Olaparib Capsule in Patients With Solid Tumours

Who this might be right for
Solid Tumours
AstraZeneca 32
Not applicableLooking for participantsNCT04793152
What this trial is testing

Vancomycin Dosing for Serious MRSA Infections: A Non-inferiority Randomized Trial of Trough Level Versus AUC/MIC

Who this might be right for
MRSA
Anthony Bai 700
Large-scale testing (Phase 3)UnknownNCT00485342
What this trial is testing

RIBAJUSTE Clinical Trial Investigating the Efficacy and Safety of Dose Adaptation of Ribavirin

Who this might be right for
Chronic Hepatitis C
Hospices Civils de Lyon 236
Early research (Phase 1)Study completedNCT04101370
What this trial is testing

Bioequivalence Study of Bosentan 125 mg Tablets Immediate Release (IR) Versus Tracleer® 125 mg Tablets IR In Healthy Subjects

Who this might be right for
Bioequivalence
Geropharm 64
Post-approval studies (Phase 4)Study completedNCT00169910
What this trial is testing

VIP: Vascular Imaging Project. Study on the Progression of Cardiovascular Disease in Renal Transplant Recipients

Who this might be right for
Cardiovascular Disease
Leiden University Medical Center 119
Not applicableStudy completedNCT00015691
What this trial is testing

Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities

Who this might be right for
HIV InfectionsLipodystrophyHyperinsulinemia
National Institute of Allergy and Infectious Diseases (NIAID) 105
Post-approval studies (Phase 4)UnknownNCT04444843
What this trial is testing

Risk Factors of Chinese Kidney Transplant Recipients DSA Based on MPA Immunosuppressive Regimen

Who this might be right for
Kidney Transplant Recipients
First Affiliated Hospital Xi'an Jiaotong University 300
Next Page